Noninvasive measure of treatment response in non‐alcoholic steatohepatitis: Insights from EMMINENCE and meta‐analysis

Noninvasive measure of treatment response in non‐alcoholic steatohepatitis: Insights from EMMINENCE and meta‐analysis

Abstract Background and Aim Liver histology changes are the current gold standard for evaluating non‐alcoholic steatohepatitis (NASH), but are limited by their invasiveness and variability for sampling and interpretation. We evaluated noninvasive biomarkers as an indication of histologic changes in...

Full description

Bibliographic Details
Main Authors: Beth A Davison, Christopher Edwards, Rohit Loomba, Stephen A Harrison, Gad Cotter, Naim Alkhouri, Gary G Koch, Howard C Dittrich
Format: Article
Language:English
Published: Wiley 2021-07-01
Series:JGH Open
Subjects:
clinical trials methodology
liver histology
non‐alcoholic steatohepatitis
serologic test
Online Access:https://doi.org/10.1002/jgh3.12575

Internet

https://doi.org/10.1002/jgh3.12575

Similar Items